Header Logo

Connection

Groesbeck Parham to Uterine Cervical Neoplasms

Back to Details
This is a "connection" page, showing publications Groesbeck Parham has written about Uterine Cervical Neoplasms.
Groesbeck Parham
Connection Strength
14.484
Uterine Cervical Neoplasms
  1. A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial. Nat Med. 2024 Sep; 30(9):2596-2604.
    View in: PubMed
    Score: 0.839
  2. Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia. Cancer Med. 2024 Jun; 13(11):e7355.
    View in: PubMed
    Score: 0.835
  3. Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia. Int J Gynaecol Obstet. 2019 Mar; 144(3):297-301.
    View in: PubMed
    Score: 0.576
  4. Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes. J Glob Oncol. 2018 09; 4:1-8.
    View in: PubMed
    Score: 0.524
  5. Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia. J Low Genit Tract Dis. 2016 Jul; 20(3):218-23.
    View in: PubMed
    Score: 0.482
  6. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. J Acquir Immune Defic Syndr. 2015 Sep 01; 70(1):e20-6.
    View in: PubMed
    Score: 0.455
  7. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015; 10(4):e0122169.
    View in: PubMed
    Score: 0.444
  8. Minimizing verification bias in cervical cancer screening of HIV-infected women. Int J Gynaecol Obstet. 2015 Mar; 128(3):269-70.
    View in: PubMed
    Score: 0.429
  9. Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. Int J Gynaecol Obstet. 2014 Jul; 126(1):88-89.
    View in: PubMed
    Score: 0.410
  10. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F32-46.
    View in: PubMed
    Score: 0.406
  11. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One. 2013; 8(9):e74607.
    View in: PubMed
    Score: 0.398
  12. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med. 2011 May; 8(5):e1001032.
    View in: PubMed
    Score: 0.338
  13. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis. 2010 Jul; 14(3):167-73.
    View in: PubMed
    Score: 0.318
  14. Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot. 2010 Jun; 17(2 Suppl):47-50.
    View in: PubMed
    Score: 0.316
  15. HPV screening for cervical cancer in rural India. N Engl J Med. 2009 Jul 16; 361(3):305; author reply 306.
    View in: PubMed
    Score: 0.298
  16. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS. 2009 Mar 27; 23(6):N1-5.
    View in: PubMed
    Score: 0.292
  17. Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ. 2008 Aug; 86(8):D-E.
    View in: PubMed
    Score: 0.279
  18. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol. 2008 Sep; 110(3):402-7.
    View in: PubMed
    Score: 0.276
  19. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008 May; 109(2 Suppl):S22-30.
    View in: PubMed
    Score: 0.274
  20. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol. 2006 Dec; 103(3):1017-22.
    View in: PubMed
    Score: 0.242
  21. Addressing disparities through coalition building: Alabama REACH 2010 lessons learned. J Health Care Poor Underserved. 2006 May; 17(2 Suppl):55-77.
    View in: PubMed
    Score: 0.238
  22. Disparities in cervical cancer screening, treatment and outcomes. Ethn Dis. 2006; 16(2 Suppl 3):S3-63-6.
    View in: PubMed
    Score: 0.233
  23. Predictors of outcomes for women with cervical carcinoma. Gynecol Oncol. 2005 Nov; 99(2):432-6.
    View in: PubMed
    Score: 0.228
  24. Economic evaluation of thermal ablation compared to cryotherapy and loop diathermy in a screen-and-treat approach to cervical cancer, Zambia. Bull World Health Organ. 2025 Sep 01; 103(9):530-540.
    View in: PubMed
    Score: 0.225
  25. Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review. Int J Gynaecol Obstet. 2024 May; 165(2):552-561.
    View in: PubMed
    Score: 0.201
  26. Comparison of cell collection and direct visualization cervical cancer screening adjuncts. Am J Obstet Gynecol. 2003 Mar; 188(3 Suppl):S13-20.
    View in: PubMed
    Score: 0.191
  27. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health. 2022 12 02; 22(1):486.
    View in: PubMed
    Score: 0.188
  28. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Int J Radiat Oncol Biol Phys. 2002 Dec 01; 54(5):1345-55.
    View in: PubMed
    Score: 0.188
  29. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. N Engl J Med. 2002 May 30; 346(22):1752-3.
    View in: PubMed
    Score: 0.182
  30. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer. 2001 Feb 15; 91(4):869-73.
    View in: PubMed
    Score: 0.166
  31. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):997-1006.
    View in: PubMed
    Score: 0.163
  32. Comparison of immediate and deferred colposcopy in a cervical screening program. Obstet Gynecol. 2000 Mar; 95(3):340-4.
    View in: PubMed
    Score: 0.156
  33. Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7--pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix. Eur J Gynaecol Oncol. 2000; 21(1):17-23.
    View in: PubMed
    Score: 0.154
  34. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020 01; 21(1):175-184.
    View in: PubMed
    Score: 0.152
  35. Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Obstet Gynecol. 1999 Jul; 94(1):78-82.
    View in: PubMed
    Score: 0.148
  36. Using Low-Cost Virtual Reality Simulation to Build Surgical Capacity for Cervical Cancer Treatment. J Glob Oncol. 2019 05; 5:1-7.
    View in: PubMed
    Score: 0.147
  37. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma. Cancer. 1998 Dec 01; 83(11):2346-52.
    View in: PubMed
    Score: 0.143
  38. Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia. Afr J Reprod Health. 2018 Dec; 22(4):92-101.
    View in: PubMed
    Score: 0.143
  39. Race as a factor in the outcome of patients with cervical cancer: lift the veil to find the wounded spirit. Gynecol Oncol. 1998 Nov; 71(2):149-50.
    View in: PubMed
    Score: 0.142
  40. Retinoic acid up-regulates the expression of major histocompatibility complex molecules and adhesion/costimulation molecules (specifically, intercellular adhesion molecule ICAM-1) in human cervical cancer. Am J Obstet Gynecol. 1998 Oct; 179(4):1020-5.
    View in: PubMed
    Score: 0.141
  41. Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer. Gynecol Oncol. 1998 Aug; 70(2):195-201.
    View in: PubMed
    Score: 0.139
  42. The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer. Int J Radiat Biol. 1998 Jun; 73(6):699-704.
    View in: PubMed
    Score: 0.138
  43. Effects of retinoic acid combined with interferon-gamma on the expression of major-histocompatibility-complex molecules and intercellular adhesion molecule-1 in human cervical cancer. Int J Cancer. 1998 Jan 19; 75(2):254-8.
    View in: PubMed
    Score: 0.134
  44. Effects of retinoic acid on the expression of a tumor rejection antigen (heat shock protein gp96) in human cervical cancer. Eur J Gynaecol Oncol. 1998; 19(3):229-33.
    View in: PubMed
    Score: 0.134
  45. Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer. Int J Radiat Oncol Biol Phys. 1997 Oct 01; 39(3):737-42.
    View in: PubMed
    Score: 0.132
  46. Point-of-care test for cervical cancer in LMICs. Oncotarget. 2016 Apr 05; 7(14):18787-97.
    View in: PubMed
    Score: 0.119
  47. Cervical Cancer Screening in Cameroon: Interobserver Agreement on the Interpretation of Digital Cervicography Results. J Low Genit Tract Dis. 2015 Oct; 19(4):288-94.
    View in: PubMed
    Score: 0.115
  48. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer. 2015 Jul 24; 15:541.
    View in: PubMed
    Score: 0.113
  49. Preference for human papillomavirus-based cervical cancer screening: results of a choice-based conjoint study in Zambia. J Low Genit Tract Dis. 2015 Apr; 19(2):119-23.
    View in: PubMed
    Score: 0.111
  50. Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study. Virol J. 2015 Jan 16; 12:2.
    View in: PubMed
    Score: 0.109
  51. Metastasis from a stage IB cervical adenocarcinoma in a transposed ovary: a case report and review of the literature. Gynecol Oncol. 1994 Dec; 55(3 Pt 1):469-72.
    View in: PubMed
    Score: 0.108
  52. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):212-5.
    View in: PubMed
    Score: 0.107
  53. Significance of a first-time atypical Papanicolaou smear in a young, high-risk African-American and Latino-American population. J Natl Med Assoc. 1994 Apr; 86(4):273-7.
    View in: PubMed
    Score: 0.103
  54. Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F73-4.
    View in: PubMed
    Score: 0.101
  55. Innovative approaches to promoting cervical health and raising cervical cancer awareness by use of existing cultural structures in resource-limited countries: experiences with traditional marriage counseling in Zambia. Glob Health Promot. 2013 Dec; 20(4 Suppl):57-64.
    View in: PubMed
    Score: 0.101
  56. 'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med. 2012 May; 74(10):1486-93.
    View in: PubMed
    Score: 0.089
  57. Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia. J Psychosom Obstet Gynaecol. 2012 Jun; 33(2):91-8.
    View in: PubMed
    Score: 0.089
  58. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila). 2012 Jan; 5(1):11-7.
    View in: PubMed
    Score: 0.088
  59. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study. Gynecol Oncol. 2006 Dec; 103(3):853-8.
    View in: PubMed
    Score: 0.060
  60. A community-driven action plan to eliminate breast and cervical cancer disparity: successes and limitations. J Cancer Educ. 2006; 21(1 Suppl):S91-100.
    View in: PubMed
    Score: 0.058
  61. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol. 2005 Nov 20; 23(33):8289-95.
    View in: PubMed
    Score: 0.057
  62. Racial disparities affecting the reproductive health of African-American women. Med Clin North Am. 2005 Sep; 89(5):935-43, 941.
    View in: PubMed
    Score: 0.057
  63. Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix. Gynecol Obstet Invest. 2003; 56(1):28-34.
    View in: PubMed
    Score: 0.049
  64. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol. 2003 Feb; 188(2):395-400.
    View in: PubMed
    Score: 0.048
  65. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol. 2001 Jun; 81(3):424-32.
    View in: PubMed
    Score: 0.042
  66. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. Clin Cancer Res. 2001 Mar; 7(3 Suppl):804s-810s.
    View in: PubMed
    Score: 0.042
  67. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. J Virol. 1999 Jul; 73(7):5402-10.
    View in: PubMed
    Score: 0.037
  68. Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-ras chimeric. Gynecol Oncol. 1997 Sep; 66(3):487-94.
    View in: PubMed
    Score: 0.033
  69. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. J Virol. 2000 May; 74(10):4729-37.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.